ration through human-relevant models, conceptual integration, and translational relevance to the clinic. By focusing on early disease mechanisms and leveraging hiPSC technology, the lab aims to contribute

adapted into real-world medical solutions. Prof. Dr. med. Tim H. Brümmendorf, Director of Medical Clinic IV and the Center for Integrated Oncology (CIO) Aachen, and spokesperson for the CIO Aachen-Bonn [...] perfectly with the Medical Faculty’s focus on ‘Organ cross talk’, ‘phase transitions in disease’, Medical Clinic IV’s specialization in chronic leukemias and stem cell disorders, and the CIO-ABCD’s emerging lighthouse

but also for patients. The location on the RWTH campus leads to an excellent cooperation between clinic, science and industry and follows the goal of developing innovative approaches in diagnostics and

Research Dr. rer. nat., Universitätsprofessor Till Marquardt RWTH Aachen University Medicine (UKA), Clinic for Neurology & Faculty for Mathematics, Informatics and Natural Sciences, Institute for Biology

for students of human medicine. In 2020, Eva started her work in research in the laboratory of the Clinic for Geriatrics at Uniklinik RWTH Aachen and gained experience in cell culture with human primary

Clinical Research in the department of Nuclear Medicine at Uniklinik RWTH Aachen

KKS - Koordinierungszentrum für Kardiologische Studien an der Medizinischen Klinik I

nat. Appointments 1996 – 2000 PhD position, Max-Planck Institute Bad Nauheim, Germany, Kerckhoff Clinic and Kerckhoff Institute, Prof. Dr. W. Risau, PD Dr. M. Clauss 2000 – 2002 Postdoc researcher, Max-Planck

of Surrey, UK Dr. Floriana Costanzo Bambino Gesù Children Hospital, Italy Prof. Paul Croarkin Mayo Clinic, USA Dr. Pushpal Desarkar CAMH, University of Toronto, Canada Dr. Katherine Dyke University of Nottingham

respect to running the lab. After Prof. C. Kosinski left the hospital, Ingrid moved to the Medical Clinic III of the University Hospital in Aachen in the research group of Prof. P. Strnad. There she was